A phase II study of irinotecan-cisplatin plus durvalumab for untreated extensive-stage small cell lung cancer (WJOG13520L, REBORN trial)

被引：0

作者：

Tachihara, M. ^{[1
]}

Shoda, H. ^{[2
]}

Akazawa, Y. ^{[3
]}

Ota, T. ^{[4
]}

Oki, M. ^{[5
]}

Sato, Y. ^{[6
]}

Sugawara, S. ^{[7
]}

Ikeda, S. ^{[8
]}

Yokoyama, T. ^{[9
]}

Kaneda, H. ^{[10
]}

Itoh, S. ^{[11
]}

Bessho, A. ^{[12
]}

Katakami, N. ^{[13
]}

Morita, S. ^{[14
,15
]}

Nakagawa, K. ^{[16
]}

Okamoto, I. ^{[17
]}

Yamamoto, N. ^{[18
]}

机构：

[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med, Kobe, Hyogo, Japan

[2] Hiroshima City Hiroshima Citizens Hosp, Dept Resp Med, Hiroshima, Japan

[3] Natl Hosp Org Toneyama Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan

[4] Izumi Municipal Hosp Canc Ctr, Med Oncol, Izumi, Japan

[5] NHO Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan

[6] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan

[7] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan

[8] Kanagawa Cardiovasc & Resp Med, Dept Resp Med, Yokohama, Kanagawa, Japan

[9] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan

[10] Osaka Metropolitan Univ, Grad Sch Med, Clin Oncol Dept, Osaka, Japan

[11] Hyogo Canc Ctr, Resp Med Dept, Akashi, Hyogo, Japan

[12] Japanese Red Cross Okayama Hosp, Dept Resp Med, Okayama, Japan

[13] Takarazuka City Hosp, Med Oncol Dept, Takarazuka, Hyogo, Japan

[14] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan

[15] Kyoto Univ, Fac Med, Kyoto, Japan

[16] Kindai Univ, Sch Med, Med Oncol Dept, Main Campus, Osaka, Japan

[17] Kyushu Univ, Dept Resp Med, Fukuoka, Japan

[18] Wakayama Med Univ, Internal Med 3, Wakayama, Japan

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.10.672

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

639P

引用

页码：S1642 / S1642

页数：1

共 50 条

[1] Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study
Ready, Neal E.
Dudek, Arkadiusz Z.
Pang, Herbert H.
Hodgson, Lydia D.
Graziano, Stephen L.
Green, Mark R.
Vokes, Everett E.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4436 - 4441
[2] Cisplatin Combined with Irinotecan or Etoposide for Untreated Extensive-Stage Small Cell Lung Cancer
Shi, Yuankai
Hu, Xingsheng
Hu, Yi
Han, Xiaohong
Li, Xue
Lin, Lin
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S625 - S625
[3] Phase II Study of Weekly Irinotecan plus Cisplatin in Patients with Previously Untreated Extensive-Stage Extrapulmonary Small Cell Carcinoma
Jin, Shidai
Wang, Tongshan
Chen, Xiaofeng
Xu, Bei
Sun, Jing
Guo, Renhua
Shu, Yongqian
ONKOLOGIE, 2011, 34 (07): : 378 - 381
[4] Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer
Araujo, Antonio M. F.
Mendez, Jose C.
Coelho, Ana L.
Sousa, Berta
Barata, Fernando
Figueiredo, Ana
Amaro, Teresina
Azevedo, Isabel
Soares, Marta
CANCER INVESTIGATION, 2009, 27 (04) : 391 - 396
[5] Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer
Araujo, Antonio M. F.
Mendez, Jose C.
Sousa, Berta
Barata, Fernando
Figueiredo, Ana
Amaro, Teresina
Coelho, Ana
Azevedo, Isabel
Soares, Marta
ANNALS OF ONCOLOGY, 2006, 17 : 232 - 232
[6] Phase II study of Celecoxib with Cisplatin plus Etoposide in extensive-stage small cell lung cancer
Araujo, Antonio M. F.
Mendez, J. Carlos
Sousa, Berta A.
Barata, Fernando
Figueiredo, Ana
Azevedo, Isabel M.
Amaro, Teresina
Sousa, Maria J.
Costa, Carla
Lopes, J. MaChado
ANNALS OF ONCOLOGY, 2004, 15 : 191 - 191
[7] A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small cell lung cancer
Bae, S.
Kim, M.
Shin, S.
Lee, K.
Hyun, M.
Song, H.
Kwon, K.
Park, K.
Lee, W.
EJC SUPPLEMENTS, 2005, 3 (02): : 338 - 338
[8] A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small cell lung cancer
Lee, Won Silk
Bae, Sung Hwa
ANNALS OF ONCOLOGY, 2007, 18 : 183 - 184
[9] DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer
Bestvina, Christine M.
Hara, Jared H. L.
Karrison, Theodore
Bowar, Benjamen
Chin, Janet
Garassino, Marina C.
Pitroda, Sean P.
Thawani, Rajat
Yokes, Everett E.
Gan, Gregory
Zhang, Jun
Baschnagel, Andrew M.
Campbell, Toby C.
Chmura, Steven
Juloori, Aditya
CLINICAL LUNG CANCER, 2024, 25 (08) : e448 - e452
[10] Phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive-stage small-cell lung cancer (WJTOG 0301)
Iwamoto, Y.
Kobayashi, M.
Matsui, K.
Yamamoto, H.
Yamazaki, K.
Saka, H.
Sawa, T.
Shibata, K.
Takeda, K.
Nakagawa, K.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →